DCOY Decoy Therapeutics Inc. - Common Stock
$3,72
Preço · Ago 19, 2026
Fundamentais a partir de Ago 12, 2026
Intervalo 52 Semanas
$1–$14
25% of range
Classificação do Analista
HOLD
6 analysts
Preço-Alvo
$30
+706% upside
P/E (TTM)
-0.0
ROE
—
Margem de Lucro Líquido
—
DCOY Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$3.72
Capitalização de Mercado
—
P/E (TTM)
-0.0
EPS (TTM)
$-129.10
Receita (TTM)
—
Rendimento div.
—
ROE
—
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $14
DCOY Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
—
2016-12-31
→
2022-12-31
EPS
$-129.10
2020-12-31
→
2025-12-31
Fluxo de caixa livre
—
2016-12-31
→
2021-12-31
Margens
—
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
DCOY
Mediana de Pares
P/E (TTM)
-0.0
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
DCOY
Mediana de Pares
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
DCOY
Mediana de Pares
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
DCOY
Mediana de Pares
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
DCOY
Mediana de Pares
DCOY Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
VENDA
6 analistas
- Compra forte 0 0,0%
- Compra 0 0,0%
- Manter 3 50,0%
- Venda 1 16,7%
- Venda forte 2 33,3%
Preço-alvo de 12 meses
1 analistas · 2026-07-24
Mín
$30.00
Máx
$30.00
Alvo mediano
$30.00
+706,5%
Alvo médio
$30.00
+706,5%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
2556.6%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Setembro de 2024 | $-136.80 | $-440.64 | 303.8% |
| 31 de Março de 2024 | $-590.40 | $-9840.96 | 9250.6% |
| 30 de Setembro de 2023 | $-936.00 | $-1762.56 | 826.6% |
| 30 de Junho de 2023 | $-2059.20 | $-1904.55 | -154.7% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DCOY | — | -0.0 | — | — | — | — |
| SBFM | — | — | — | — | — | — |
| SHPH | $4M | -0.3 | 0.00% | — | -400.1% | — |
| ADTX | $343.6K | -0.0 | -97.6% | -1349028.2% | -1183.4% | 8.4% |
| GNPX | $6M | — | — | — | -347.0% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | $0 | $2M | $5M | $3M | $2M | $1M | $1M | $0 | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | $430.8K | $506.5K | $662.7K | $0 | $0 | |
| R&D Expense | $368.2K | $770.0K | $7M | $16M | $9M | $7M | $4M | $1M | $17M | $20M | $13M | $4M | |
| SG&A Expense | $4M | $5M | $6M | $7M | $6M | $6M | $8M | $2M | $19M | $20M | $16M | $4M | |
| Operating Expenses | $13M | $6M | $13M | $32M | $15M | $13M | $12M | $4M | $36M | $41M | $29M | $8M | |
| Operating Income | $-13M | $-6M | $-13M | $-32M | $-13M | $-8M | $-8M | $-2M | $-35M | $-40M | $-29M | $-8M | |
| Interest Income | · | · | · | · | · | · | · | $152.0K | $292.0K | $393.1K | $72.0K | $18.9K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | $-29M | $-8M | |
| Income Tax | $0 | · | · | · | · | · | $0 | · | · | · | · | · | |
| Net Income | $-13M | $-6M | $-13M | $-32M | $-13M | $-7M | $-7M | $-2M | $-34M | $-39M | $-29M | $-8M | |
| EPS (Basic) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · | |
| EPS (Diluted) | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 | $-0.50 | · | · | · | · | · | · | |
| Shares (Basic) | 96,967 | 80,184 | 408,078 | 2,124,511 | 1,654,638 | 15,578,611 | · | · | · | · | · | · | |
| Shares (Diluted) | 96,967 | 80,184 | 408,078 | 2,124,511 | 1,654,638 | 15,578,611 | · | · | · | · | · | · | |
| EBITDA | · | $-6M | · | $-32M | $-13M | $-8M | $-8M | · | $-35M | $-40M | · | · |
Balanço Patrimonial 26
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $2M | $6M | $12M | $29M | $11M | $4M | $3M | $19M | $22M | $67M | $34M | |
| Short-term Investments | · | · | · | · | · | · | · | $0 | $14M | $39M | $25M | $0 | |
| Receivables | · | · | · | · | $2M | $4M | $0 | $9.9K | $10.4K | $12.2K | $0 | · | |
| Inventory | · | · | · | · | · | · | · | $186.9K | $431.9K | $454.1K | $0 | · | |
| Prepaid Expense | $275.2K | $553.0K | $619.8K | $803.4K | $949.2K | $822.0K | $955.9K | $249.1K | $777.1K | $926.0K | $908.6K | $370.4K | |
| Other Current Assets | $275.2K | $43.7K | $151.3K | $167.6K | $173.0K | $137.8K | $136.1K | $22.3K | · | · | · | · | |
| Current Assets | $11M | $3M | $7M | $15M | $30M | $16M | $5M | $6M | $35M | $62M | $92M | $34M | |
| PP&E (Net) | $40.6K | $0 | · | · | $7.9K | $22.6K | $25.0K | $37.5K | $331.0K | $556.3K | $382.4K | $85.1K | |
| PP&E (Gross) | · | · | · | · | · | · | · | $875.6K | $953.9K | $879.3K | $442.5K | $97.1K | |
| Accum. Depreciation | · | · | · | · | · | · | · | $801.1K | $622.9K | $323.0K | $60.1K | $12.0K | |
| Goodwill | · | · | · | $0 | $9M | $9M | $9M | $0 | · | · | · | · | |
| Other Non-current Assets | $31.0K | $35.4K | $66.8K | $130.5K | $193.9K | $247.1K | $308.7K | $195.4K | $0 | $64.8K | $0 | $50.0K | |
| Total Assets | $11M | $3M | $7M | $15M | $41M | $25M | $14M | $7M | $35M | $63M | $95M | $36M | |
| Accounts Payable | $940.6K | $937.0K | $602.9K | $3M | $2M | $2M | $2M | $379.8K | $2M | $1M | $875.6K | $578.7K | |
| Short-term Debt | $0 | $221.9K | $289.6K | $0 | $0 | $477.0K | $502.3K | $0 | · | · | · | · | |
| Current Liabilities | $5M | $2M | · | · | · | · | · | $1M | $6M | $4M | $3M | $1M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $0 | $15.4K | $15.4K | |
| Total Liabilities | $5M | $2M | $1M | $4M | $2M | $3M | $3M | $8M | $6M | $4M | $3M | $1M | |
| Total Debt | · | $221.9K | · | · | $0 | $477.0K | $502.3K | · | · | · | · | · | |
| Common Stock | $53 | $1 | $49 | $225 | $181 | $2.4K | $451 | $203 | $1.8K | $1.7K | $1.6K | $221 | |
| Paid-in Capital | $100M | $83M | $82M | $74M | $71M | $42M | $23M | $4M | $140M | $136M | $129M | $1M | |
| Retained Earnings | $-94M | $-82M | $-76M | $-64M | $-32M | $-19M | $-12M | $-5M | $-111M | $-77M | $-37M | $-8M | |
| AOCI | · | · | · | · | · | · | · | $0 | $-1.2K | $-1.6K | $-24.7K | $0 | |
| Stockholders' Equity | $6M | $2M | $5M | $10M | $39M | $22M | $11M | $-1M | $-3M | $59M | $92M | $-7M | |
| Liabilities + Equity | $11M | $3M | $7M | $15M | $41M | $25M | $14M | $7M | $35M | $63M | $95M | $36M | |
| Shares Outstanding | 531,968 | 8,006 | 2,735 | 281,987 | 1,809,593 | 23,808,546 | 4,511,174 | 2,032,763 | 1,178,604 | 16,773,798 | 15,741,618 | 2,215,711 |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7.2K | $4.4K | $10.1K | $6.7K | $19.2K | $18.1K | $127.4K | $16.9K | · | · | · | · | |
| Stock-based Comp | $219.1K | $273.7K | $524.8K | $796.8K | $559.0K | $319.4K | $751.6K | $31.0K | $4M | $7M | $7M | $1M | |
| Restructuring | · | · | · | · | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | $772.3K | · | $13M | $2M | $-3M | $-6M | · | · | · | · | · | |
| Operating Cash Flow | $-5M | $-5M | $-13M | $-18M | $-10M | $-10M | $-12M | $4M | $-28M | $-32M | $-21M | $-6M | |
| CapEx | $577.0K | $0 | · | · | $0 | $2.6K | $0 | $0 | $113.5K | $559.4K | $265.6K | $76.1K | |
| Investing Cash Flow | $764.7K | $0 | $0 | $-2M | $0 | $-2.6K | $6M | $0 | $24M | $-12M | $-27M | $-76.1K | |
| Stock Issued | · | · | · | · | · | · | · | $3M | · | · | · | · | |
| Dividends Paid | · | · | · | · | · | $0 | $133.6K | $0 | · | · | · | · | |
| Financing Cash Flow | $12M | $1M | $7M | $2M | $28M | $18M | $4M | $1M | $2.6K | $22.1K | $81M | $40M | |
| Net Change in Cash | $8M | $-3M | $-6M | $-17M | $18M | $7M | $-2M | $6M | $-3M | $-44M | · | · | |
| Free Cash Flow | · | · | · | · | $-10M | $-10M | · | · | $-28M | $-33M | $-21M | $-7M |
Lucratividade 5
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -696.3% | -148.8% | -238.5% | · | -2724.7% | -3946.5% | · | · | |
| Net Margin | · | · | · | · | -693.8% | -140.5% | -200.2% | · | -2701.7% | -3907.7% | · | · | |
| EBITDA Margin | · | · | · | · | -695.2% | -148.4% | -234.8% | · | -2724.7% | -3946.5% | · | · | |
| ROA | · | -116.1% | · | -113.9% | -38.8% | -37.9% | -67.6% | · | -70.1% | -49.9% | -44.6% | -45.0% | |
| ROE | · | -251.4% | · | -234.2% | -31.4% | -34.4% | -68.3% | · | -77.9% | -52.1% | -68.0% | 245.0% |
Liquidez e Solvência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | · | · | · | · | · | 5.9 | 16.1 | 32.4 | 32.1 | |
| Quick Ratio | · | · | · | · | · | · | · | · | 5.7 | 15.7 | 32.1 | 31.7 | |
| Debt / Equity | · | 0.1 | · | · | 0.0 | 0.0 | 0.0 | · | · | · | · | · |
Eficiência 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.3 | 0.3 | · | 0.0 | 0.0 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 1.1 | 2.9 | · | · | |
| Receivables Turnover | · | · | · | · | 0.7 | 2.7 | · | · | 113.0 | 165.9 | · | · |
Taxas de Crescimento 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | · | -64.8% | · | · | · | · | · | · | · |
Avaliação (TTM) 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $2M | $5M | $3M | $2M | $1M | $1M | $0 | $0 | |
| Net Income TTM | $-13M | $-6M | $-13M | $-32M | $-13M | $-7M | $-7M | $-2M | $-34M | $-39M | $-29M | $-8M | |
| Market Cap | · | $40M | · | · | · | · | · | · | · | · | · | · | |
| Enterprise Value | · | $38M | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | -0.4 | · | · | · | · | · | · | · | · | · | · | |
| P/B | · | 26.3 | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.1 | 26.3 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -8.8 | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | -6.6 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -19892.1% | -252.0% | · | · | · | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | · | 0.00% | -1.9% | · | · | · | · | · | |
| Annual Payout | · | · | · | · | · | $0 | $133.6K | $0 | · | · | · | · |
Demonstração de Resultados 11
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $227.6K | · | · | · | $0 | · | · | · | · | · | · | · | · | $0 | · | $0 | |
| R&D Expense | $1M | $749.8K | $114.4K | $61.8K | $116.4K | $75.5K | $175.3K | $137.2K | $214.4K | $243.0K | $60.0K | $1M | $2M | $4M | $5M | $4M | |
| SG&A Expense | $1M | $2M | $402.2K | $833.3K | $849.2K | $2M | $1M | $869.2K | $1M | $2M | $910.7K | $1M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $3M | $2M | $9M | $895.1K | $965.6K | $2M | $1M | $1M | $1M | $2M | $970.7K | $3M | $4M | $5M | $6M | $14M | |
| Operating Income | $-3M | $-2M | $-9M | $-895.1K | $-965.6K | $-2M | $-1M | $-1M | $-1M | $-2M | $-970.7K | $-3M | $-4M | $-5M | $-6M | $-14M | |
| Net Income | $-2M | $-2M | $-9M | $-873.5K | $-957.8K | $-2M | $-1M | $-972.1K | $-1M | $-2M | $-881.8K | $-2M | $-4M | $-5M | $-6M | $-14M | |
| EPS (Basic) | $-4.46 | $-4.18 | $-125.81 | $-1.81 | $-81.21 | $-240.07 | $-52.52 | $-11.38 | $-2.37 | $-3.27 | $-11.85 | $-5.21 | $-11.45 | $-2.23 | $-2.97 | $-6.41 | |
| EPS (Diluted) | $-4.46 | $-4.18 | $-125.81 | $-1.81 | $-81.21 | $-240.07 | $-52.52 | $-11.38 | $-2.37 | $-3.27 | $-11.85 | $-5.21 | $-11.45 | $-2.23 | $-2.97 | $-6.41 | |
| Shares (Basic) | 531,968 | 531,968 | -4,171,414 | 481,587 | 11,794 | 7,121 | -1,130,017 | 85,458 | 600,417 | 524,326 | -2,791,778 | 469,254 | 338,638 | 2,391,964 | -4,114,349 | 2,247,753 | |
| Shares (Diluted) | 531,968 | 531,968 | -4,171,414 | 481,587 | 11,794 | 7,121 | -1,130,017 | 85,458 | 600,417 | 524,326 | -2,791,778 | 469,254 | 338,638 | 2,391,964 | -4,114,349 | 2,247,753 | |
| EBITDA | $-3M | $-2M | · | $-895.1K | $-965.6K | $-2M | · | $-1M | $-1M | $-2M | · | $-3M | $-4M | $-5M | · | $-14M |
Balanço Patrimonial 20
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $8M | $11M | $5M | $794.9K | $2M | $2M | $3M | $3M | $4M | $6M | $8M | $12M | $9M | $12M | $17M | |
| Receivables | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Prepaid Expense | $284.2K | $537.0K | $275.2K | $1M | $564.7K | $506.7K | $553.0K | $538.6K | $241.1K | $457.1K | $619.8K | $743.2K | $284.8K | $536.6K | $803.4K | $1M | |
| Other Current Assets | $146.1K | $305.8K | $275.2K | $80.9K | $26.5K | $61.6K | $43.7K | $119.0K | $151.6K | $178.1K | $151.3K | $83.1K | $174.4K | $156.5K | $167.6K | $248.7K | |
| Current Assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $18M | |
| PP&E (Net) | $399.1K | $35.7K | $40.6K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Other Non-current Assets | $28.8K | $29.9K | $31.0K | $32.1K | $33.2K | $34.3K | $35.4K | $36.5K | $39.9K | $53.4K | $66.8K | $80.4K | $99.0K | $114.9K | $130.5K | $146.5K | |
| Total Assets | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $20M | |
| Accounts Payable | $1M | $936.0K | $940.6K | $1M | $1M | $1M | $937.0K | $165.8K | $643.1K | $714.0K | $602.9K | $1M | $2M | $4M | $3M | $2M | |
| Short-term Debt | · | · | $0 | $0 | $0 | $112.2K | $221.9K | $328.8K | $0 | $116.9K | $289.6K | $459.1K | · | · | $0 | · | |
| Current Liabilities | $5M | $5M | $5M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $5M | $5M | $5M | $2M | $2M | $2M | $2M | $934.6K | $1M | $1M | $1M | $2M | $4M | $4M | $4M | $3M | |
| Total Debt | · | · | · | $0 | $0 | $112.2K | · | $328.8K | $0 | $116.9K | · | $459.1K | · | · | · | · | |
| Common Stock | $53 | $53 | $53 | $94 | $213 | $208 | $1 | $144 | $64 | $431 | $49 | $394 | $335 | $246 | $225 | $224 | |
| Paid-in Capital | $103M | $101M | $100M | $90M | $84M | $84M | $83M | $83M | $82M | $82M | $82M | $82M | $81M | $75M | $74M | $74M | |
| Retained Earnings | $-99M | $-97M | $-94M | $-85M | $-85M | $-84M | $-82M | $-80M | $-79M | $-78M | $-76M | $-75M | $-73M | $-69M | $-64M | $-57M | |
| Stockholders' Equity | $4M | $4M | $6M | $4M | $-829.7K | $61.9K | $2M | $3M | $2M | $4M | $5M | $6M | $8M | $6M | $10M | $17M | |
| Liabilities + Equity | $9M | $8M | $11M | $6M | $1M | $2M | $3M | $4M | $4M | $5M | $7M | $8M | $12M | $10M | $15M | $20M | |
| Shares Outstanding | 531,968 | 531,968 | 531,968 | 944,491 | 2,127,286 | 2,081,839 | 8,006 | 1,441,157 | 641,177 | 4,314,433 | 492,304 | 3,938,433 | 3,352,069 | 2,468,297 | 2,255,899 | 2,249,371 |
Fluxo de Caixa 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $13.6K | $5.9K | $3.8K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $5.6K | $1.7K | $1.7K | $1.7K | $1.7K | |
| Stock-based Comp | $206.2K | $213.0K | $139.5K | $22.8K | $23.2K | $33.5K | $51.0K | $60.0K | $85.2K | $77.5K | $85.4K | $112.7K | $123.5K | $203.3K | $145.5K | $137.9K | |
| Other Non-cash | · | $-883.7K | · | · | · | $493.2K | · | · | · | $282.7K | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-3M | $-3M | $-1M | $-2M | $-862.3K | $-1M | $-742.5K | $-1M | $-1M | $-1M | $-2M | $-4M | $-4M | $-3M | $-5M | $-6M | |
| Investing Cash Flow | · | · | $964.7K | $-200.0K | · | · | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | |
| Financing Cash Flow | $3M | $0 | $6M | $6M | $-141.2K | $545.6K | $-107.0K | $1M | $-28.2K | $-172.8K | $-169.4K | $-211.8K | $7M | $336.7K | $1 | $-85.7K | |
| Net Change in Cash | $468.5K | $-3M | $6M | $4M | $-1M | $-636.1K | $-849.5K | $11.2K | $-1M | $-2M | $-2M | $-4M | $2M | $-3M | $-5M | $-6M |
Lucratividade 5
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1155.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | -1042.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -1155.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -45.7% | -41.3% | · | -17.5% | -38.7% | -47.3% | · | -15.8% | -18.2% | -23.0% | · | -17.4% | -17.0% | -23.4% | · | -45.0% | |
| ROE | -136.0% | -112.9% | · | -24.4% | -123.9% | -92.1% | · | -21.6% | -26.4% | -37.2% | · | -21.5% | -19.7% | -27.4% | · | -48.6% |
Liquidez e Solvência 3
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Quick Ratio | 1.8 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 1.8 | · | 0.1 | 0.0 | 0.0 | · | 0.1 | · | · | · | · |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.0 |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-6M | $-6M | · | $-5M | $-5M | $-6M | · | $-7M | $-9M | $-13M | · | $-26M | $-28M | $-31M | · | $-29M | |
| Market Cap | $4M | $3M | · | $3M | $29M | $24M | · | $31M | $23M | $274M | · | · | · | · | · | · | |
| Enterprise Value | · | · | · | $-1M | $28M | $22M | · | $28M | $20M | $270M | · | · | · | · | · | · | |
| P/E | -0.1 | -0.0 | · | -0.3 | -0.9 | -0.6 | · | -1.0 | -1.6 | -2.9 | · | · | · | · | · | · | |
| P/B | 0.9 | 0.9 | · | 0.8 | -34.5 | 380.6 | · | 10.6 | 9.6 | 75.0 | · | · | · | · | · | · | |
| P / Tangible Book | 0.9 | 0.9 | · | 0.8 | · | 380.6 | · | 10.6 | 9.6 | 75.0 | · | · | · | · | · | · | |
| P / Cash Flow | · | -1.2 | · | · | · | -19.9 | · | · | · | -202.3 | · | · | · | · | · | · | |
| EV / EBITDA | · | · | · | 1.5 | -28.8 | -12.7 | · | -28.0 | -13.4 | -152.3 | · | · | · | · | · | · | |
| Earnings Yield | -1274.8% | -3774.5% | · | -399.7% | -113.3% | -159.6% | · | -102.9% | -62.5% | -34.9% | · | · | · | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | — | — | — | $0 | $2M |
| Margem Operacional % | — | — | — | — | -696.3% |
| Lucro líquido | $-13M | $-6M | $-13M | $-32M | $-13M |
| EPS Diluído | $-129.10 | $-69.54 | $-30.74 | $-14.88 | $-7.72 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | 0.1 | — | — | 0.0 |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | — | — | — | — | $-10M |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F)
Atividade institucional — Q4 2025 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 5 | 1 | 2 | 0 | — |
Comparado a Q3 2025. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado. Variação vs trimestre anterior não mostrada: a cobertura de registrantes difere demais entre esses dois trimestres para uma comparação confiável.
Executivos da empresa 11 insiders · 1 diretores · 9 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| David J. Arthur | Chief Executive Officer | 11 de Fevereiro de 2020 P | 81.546 | 0 | 0 | $0 |
| Jonathan P Northrup | Conselheiro | 11 de Fevereiro de 2020 P | 352.713 | 0 | 0 | $0 |
| Bruce J Mccreedy Jr. | Conselheiro | 11 de Fevereiro de 2020 P | 8.700 | 0 | 0 | $0 |
| Tess Burleson | Conselheiro | 11 de Fevereiro de 2020 P | 4.350 | 0 | 0 | $0 |
| William K. Mcvicar | Conselheiro | 11 de Fevereiro de 2020 P | 8.700 | 0 | 0 | $0 |
| Arnold C Hanish | Conselheiro | 11 de Fevereiro de 2020 P | 7.350 | 0 | 0 | $0 |
| Jeffrey D Capello | Conselheiro | 29 de Junho de 2015 A | — | 0 | 0 | $0 |
| SCULLEY JOHN | Conselheiro | 29 de Junho de 2015 A | 54.402 | 0 | 0 | $0 |
| Peter Barton Hutt | Conselheiro | 3 de Fevereiro de 2015 C | 11.675 | 0 | 0 | $0 |
| Longwood Fund II, L.P. | Detentor de 10% | 16 de Outubro de 2018 S | 0 | 0 | 0 | $0 |
| Christoph H Westphal | Detentor de 10% | 16 de Outubro de 2018 S | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 10 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Elvin Lee | 27 de Outubro de 2023 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 21 de Fevereiro de 2020 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 21 de Fevereiro de 2020 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada, Pessoa de relato não divulgada | 29 de Julho de 2019 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 29 de Julho de 2019 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 29 de Julho de 2019 | — | Declaração inicial | — | SEC |
| Boston Foundation, Inc. (2) ×2 declarações | 17 de Janeiro de 2019 | — | Declaração inicial | — | SEC |
| Christoph Westphal, M.D., Ph.D. ×2 declarações | 21 de Dezembro de 2018 | — | Declaração inicial | — | SEC |
| Longwood Fund II, L.P., Longwood Fund III, L.P., Longwood Fund II GP, LLC, Longwood Fund III GP, LLC, Christoph Westphal, M.D., Ph.D., Richard Aldrich ×3 declarações | 26 de Outubro de 2018 | — | Declaração inicial | — | SEC |
| Longwood Fund II, L.P. (2), Longwood Fund II GP, LLC (2), Christoph Westphal, M.D., Ph.D. (2), Richard Aldrich (2), Michelle Dipp, M.D., Ph.D. (2) | 19 de Fevereiro de 2015 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 1 ETF
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de Julho de 2026 | Diário |